Stock Detail
QUEST DIAGNOSTICS INCORPORATED
Health Services
DGX @ Yahoo Finance | DGX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $55.30 | $56.35 | $-1.40 | -2.47% | 0.40 | $56.70 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $55.97 | $55.25 | 1.05M | 8.72B | 1.73M | 20.29 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 56.73 | 56.01 | 55.63 | 54.91 | 54.53 |
Stock Profile
Quest Diagnostics Incorporated provides diagnostic testing, information, and services for the healthcare industry in the United States. It offers esoteric testing, such as gene-based testing and testing for drugs of abuse; and anatomic pathology services and testing to support clinical trials of new pharmaceuticals worldwide. Quest Diagnostics manufactures and markets diagnostic test kits and systems primarily for esoteric testing, which are sold to hospitals, clinical laboratories, and dialysis centers domestically and internationally, through its subsidiary, Nichols Institute Diagnostics. The company offers a range of clinical laboratory testing services to patients, physicians, hospitals, healthcare insurers, employers, governmental institutions, and other commercial clinical laboratories. It operates a network of approximately 1,900 patient service centers and laboratories located in approximately 30 metropolitan areas in the United States. The company markets its products to customers through its direct sales force, healthcare insurers sales force, customer service representatives, and couriers. Quest Diagnostics is headquartered in Lyndhurst, New Jersey.